Letters
Gender dysphoria
What are the risks of oestrogens in women assigned male at birth and how should they be monitored?
BMJ 2017; 358 doi: https://doi.org/10.1136/bmj.j4166 (Published 11 September 2017) Cite this as: BMJ 2017;358:j4166
- Jacq Hawkins, general practitioner
- Central Lakes Medical Practice, Ambleside LA22 9BP, UK
- jlavender62{at}gmail.com
As a general practitioner, I am uncertain about hormonal treatment and its monitoring in patients with gender dysphoria. Barrett mentions that women who were assigned male at birth do not need screening mammography because their risk of breast cancer is very low as their hormonal treatment does not include progestogens.1 What are the other risks …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £173 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£38 / $45 / €42 (excludes VAT)
You can download a PDF version for your personal record.